Omnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
SymbolNYSE:OCR
CUSIP68190410
Phone+1-513-7192600
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins1.96%
Return on Equity5.37%
Return on Assets2.20%
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$9,480.00
Omnicare (NYSE:OCR) Frequently Asked Questions
What is Omnicare's stock symbol?
Omnicare trades on the New York Stock Exchange (NYSE) under the ticker symbol "OCR."
How were Omnicare's earnings last quarter?
Omnicare, Inc. (NYSE:OCR) released its earnings results on Wednesday, February, 19th. The healthcare company reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.90 by $0.03. The healthcare company earned $1.54 billion during the quarter, compared to analysts' expectations of $1.59 billion. Omnicare had a net margin of 1.96% and a return on equity of 5.37%. View Omnicare's Earnings History.
What is the consensus analysts' recommendation for Omnicare?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicare in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Has Omnicare been receiving favorable news coverage?
Press coverage about OCR stock has been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Omnicare earned a media sentiment score of 0.07 on Accern's scale. They also assigned news headlines about the healthcare company an impact score of 45.56 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of Omnicare?
Shares of OCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Omnicare's stock price today?
One share of OCR stock can currently be purchased for approximately $97.90.
How big of a company is Omnicare?
Omnicare has a market capitalization of $9.48 billion.
How can I contact Omnicare?
Omnicare's mailing address is 900 Omnicare Center 201 E. Fourth Street, CINCINNATI, OH 45202-4248, United States. The healthcare company can be reached via phone at +1-513-7192600.
MarketBeat Community Rating for Omnicare (NYSE OCR)
MarketBeat's community ratings are surveys of what our community members think about Omnicare and other stocks. Vote "Outperform" if you believe OCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
